Jiangxi: Thriving on New Growth Drivers NANCHANG, China, Nov. 18, 2024 /PRNewswire/ — A report from Jiangxi International Communication… CISION PRNewswireNovember 18, 2024
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets Biosion receives over $40 million cash payment as upfront license fee and… CISION PRNewswireNovember 18, 2024
Latin Americans have confidence in partnership with China BEIJING, Nov. 18, 2024 /PRNewswire/ — Chinese President Xi Jinping arrived in Rio… CISION PRNewswireNovember 18, 2024
Press ReleaseTalentCorp Launches Landmark Study on Workforce Impact of AI, Digitalisation, and Green Economy Informed by Industry Research, Comprehensive Programmes to Bridge Skills Gap through Reskilling… CISION PRNewswireNovember 18, 2024
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit HONG KONG, Nov. 18, 2024 /PRNewswire/ — Akeso Biopharma (9926. HK) ("Akeso"… CISION PRNewswireNovember 18, 2024
Press ReleaseEternal Group Unveiled the <2024 Hong Kong and Macau Perfume and Home Fragrance White Paper> at Cosmoprof Asia 2024 HONG KONG, Nov. 18, 2024 /PRNewswire/ — Eternal Group is delighted to… CISION PRNewswireNovember 18, 2024
VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate SHANGHAI and BOSTON, Nov. 18, 2024 /PRNewswire/ — VelaVigo Cayman Limited (VelaVigo),… CISION PRNewswireNovember 18, 2024
Press ReleaseWELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday BOLINGBROOK, Ill. , Nov. 18, 2024 /PRNewswire/ — Stock up your family’s medicine cabinet… CISION PRNewswireNovember 18, 2024
